Transcriptional upregulation of the chemokine receptor 4 gene (CXCR4) in organ-confined tumor cells that overexpress the ETS-related gene ERG (i.e., TMPRSS2-ERG fusion) increases the motility of prostate tumor cells in vitro [8]. The gene discussed is ERG; the disease is prostate neoplasm.